AIM
ZYME icon

AXA Investment Managers’s Zymeworks ZYME Stock Holding History

AXA Investment Managers’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.71M Buy
+158,416
New +$2.27M 0.01% 710

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

AXA Investment Managers's ZYME Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Zymeworks (ZYME) in Q3 2025: 158,416 shares worth $2.71M. The stake represents 0.01% of the portfolio and ranks #710 among its holdings.

183 funds tracked by Wall St. Rank hold ZYME as of Q3 2025.

  • AXA Investment Managers held 158,416 shares of Zymeworks worth $2.71M as of Q3 2025.
  • Zymeworks was a new AXA Investment Managers position in Q3 2025.
  • Zymeworks made up 0.01% of AXA Investment Managers's portfolio in Q3 2025, its #710 holding.
  • 183 funds tracked by Wall St. Rank held Zymeworks as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.